Newborn screening of cystinosis in Germany

For routine newborn screening (NBS) of nephropathic cystinosis, a rare hereditary disease, we developed a novel two-tiered genetic approach by screening for the most common mutations by qPCR followed by next-generation sequencing as a second tier test to detect rare variants.